T3 Companies’s Aimei Health Technology Co Right AFJKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.94K Buy
17,132
+2,429
+17% +$677 ﹤0.01% 163
2026
Q1
$4.53K Hold
14,703
0.01% 135
2025
Q4
$5.5K Buy
+14,703
New +$5.54K 0.01% 172

Other funds holding AFJKR

T3 Companies's AFJKR Position: Q2 2026 in Review

T3 Companies increased its Aimei Health Technology Co Right (AFJKR) stake by 17% in Q2 2026, buying an estimated $677 and bringing the position to 17,132 shares worth $3.94K. The position accounts for ﹤0.01% of the portfolio, ranked #163.

T3 Companies first reported a position in AFJKR in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.5K in Q4 2025. 15 funds tracked by Wall St. Rank hold AFJKR as of Q2 2026.

  • T3 Companies held 17,132 shares of Aimei Health Technology Co Right worth $3.94K as of Q2 2026.
  • T3 Companies bought 2,429 Aimei Health Technology Co Right shares in Q2 2026, an estimated $677.
  • Aimei Health Technology Co Right made up ﹤0.01% of T3 Companies's portfolio in Q2 2026, its #163 holding.
  • T3 Companies first reported a position in Aimei Health Technology Co Right in Q4 2025 and has held it in 3 quarters since.
  • T3 Companies's Aimei Health Technology Co Right position peaked at $5.5K in Q4 2025.
  • 15 funds tracked by Wall St. Rank held Aimei Health Technology Co Right as of Q2 2026.

Based on T3 Companies's 13F filing for Q2 2026, filed 27 Jul 2026.